Acute Leukemia Diagnostic & Prognostic Panel

This panel helps diagnose acute leukemia by analyzing genetic markers and abnormalities associated with the disease.

Also known asAlpd Acute Leukemia Prognostic Disease Panel Acute Leukemia Prognostic Disease Panel

Available via

Home Collection, Lab Visit

Contains

91 parameters

Earliest reports in

10 Working Days

Test details
Preparations

No special preparations needed

Test included
Acute Leukemia Diagnostic & Prognostic Panel includes 91 parameters

  • Specimen
  • Indications
  • Cells Counted & Analysed
  • Cells Karyotyped
  • Karyotype

  • Cd45

  • Cd1a
  • Cd2
  • Cd3
  • Cd4
  • Cd5
  • Cd7
  • Cd8
  • Cd56
  • Cytoplasmic Cd3

  • Cd10
  • Cd19
  • Cd10/cd19 (co-expression)
  • Cd20
  • Cd22
  • Cytoplasmic Cd79a
  • Smigm

  • Cd11b
  • Cd13
  • Cd14
  • Cd15
  • Cd16
  • Cd33
  • Cd64
  • Cd117
  • Cytoplasmic Myeloperoxidase

  • Cd34
  • Hla Dr

  • Specimen
  • Clinical Indications
  • Total Number Of Cells
  • Interpretation

  • Instrument/software Used
  • Cell Preparation Method
  • Gating Strategy
  • Specimen Type
  • Wbc Count
  • Blast

  • Specimen Source
  • Preliminary Report
  • T(1;19) (q23; P13)
  • T(9; 22) (q34; Q11)
  • T(4;11) (q21; Q23)
  • T(11;19) (q23;p13.1)
  • Rbm15-mkl1 [t(1;22)]
  • Dek-can [t( 6;9)]
  • Set-can [t(9;9)]

  • Specimen Source
  • Preliminary Report
  • Flt3 Itd Mutation
  • Flt3 Itd Signal Ratio (mutant: Wildtype)
  • Flt3 D835 Mutation
  • Clinical Details

  • Specimen Source
  • Preliminary Report
  • Npm1 Mutation
  • Clinical Details

  • Preliminary Report
  • C-kit Mutation
  • Specimen Source
  • Clinical Details

  • Specimen Source
  • Preliminary Report
  • Cebpa Mutation

  • E2a-pbx1 T(1;19)
  • Aml1-eto T(8;21)
  • Cbfb-myh11 Inv 16
  • Bcr-abl1 T(9; 22)
  • Mll-af4 T(4;11)
  • Tel-aml1 T(12; 21)
  • Pml-rara T(15; 17)
  • Mll-af6 T(6;11)
  • Mll-af9 T(9;11)
  • Mll-af10 T(10;11)
  • Mll-enl T(11;19)
  • Rbm15-mkl1 [t(1;22)]
  • Dek-can [t( 6;9)]
  • Set-can [t(9;9)]

  • Specimen
  • Clinical Indications
  • Total Number Of Cells
  • Interpretation

  • Interpretation

  • Interpretation

  • Interpretation

  • Interpretation

Test code

8043

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers16 ML
Bone Marrow HeparinGreen Vacutainer3 ML
Edta Whole BloodLavender Vacutainer15 ML
Heparin Whole BloodGreen Vacutainer24 ML
SmearOthers11 NOS

Specimen stability information

Bone Marrow, Edta Whole Blood, Heparin Whole Blood, Smear

Specimen rejection criteria

Test run frequency

'

Turn around time

10 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d
  • Flow Cytometry
  • Cytogenetics

CPT and Loinc codes

Acute Leukemia Diagnostic & Prognostic Panel

30000